Back
DoubleLine Yield Opportunities Fund Vs. Astrana Health Industry Stock Comparison
Sell
46
DLY
DoubleLine Yield Opportunities Fund
Last Price:
16.07
Seasonality Move:
4.62%
Sell
21
ASTH
Astrana Health
Last Price:
41.9300
Seasonality Move:
25.02%
Sell
46
DoubleLine Yield Opportunities Fund (DLY)
is a Sell
Is DoubleLine Yield Opportunities Fund a Buy, Sell or Hold?
- The current DoubleLine Yield Opportunities Fund [DLY] share price is $16.09. The Score for DLY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $41.9500. The Score for ASTH is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DLY Stock Price Chart
What is DoubleLine Yield Opportunities Fund's stock price today?
-
The DoubleLine Yield Opportunities Fund share price today is $16.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DLY is experiencing slight selling pressure.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $41.9500
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing selling pressure, which indicates risk of future bearish movement.
DLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.77 | Sell |
| Chaikin Money Flow: | -82563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.86 - 16.42) | Sell |
| Bollinger Bands (100): | (15.91 - 16.49) | Sell |
ASTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.69 | Sell |
| Relative Strength Index (14 RSI): | 26 | Sell |
| Chaikin Money Flow: | -502206 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.0668 - 60.5468) | Sell |
| Bollinger Bands (100): | (44.6599 - 56.9799) | Sell |
DLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.23 | Sell |
| 20-day SMA: | 16.05 | Buy |
| 50-day SMA: | 16.34 | Sell |
| 200-day SMA: | 15.9 | Buy |
| 8-day EMA: | 16.21 | Sell |
| 20-day EMA: | 16.17 | Sell |
| 50-day EMA: | 16.22 | Sell |
| 200-day EMA: | 15.85 | Buy |
ASTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.93 | Sell |
| 20-day SMA: | 54.52 | Sell |
| 50-day SMA: | 55.01 | Sell |
| 200-day SMA: | 45.31 | Sell |
| 8-day EMA: | 48.78 | Sell |
| 20-day EMA: | 52.72 | Sell |
| 50-day EMA: | 53.52 | Sell |
| 200-day EMA: | 46.84 | Sell |
DoubleLine Yield Opportunities Fund Earnings Growth & DLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
DoubleLine Yield Opportunities Fund Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astrana Health Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||